Alzheimer's disease and its treatment by different approaches: A review

S Srivastava, R Ahmad, SK Khare - European Journal of Medicinal …, 2021 - Elsevier
Alzheimer's disease (AD) is a neurodegenerative disorder that impairs mental ability
development and interrupts neurocognitive function. This neuropathological condition is …

Advancements in nanotherapeutics for Alzheimer's disease: current perspectives

S Harilal, J Jose, DGT Parambi, R Kumar… - Journal of Pharmacy …, 2019 - academic.oup.com
Objectives Considerable progress has been made in the treatment of Alzheimer's disease
(AD), but all available strategies focus on alleviating symptoms rather than curing, which …

Novel therapeutic strategies for Alzheimer's disease: Implications from cell-based therapy and nanotherapy

H Derakhshankhah, S Sajadimajd, S Jafari… - … , Biology and Medicine, 2020 - Elsevier
Alzheimer's disease (AD) is a multifactorial neurodegenerative disease which leads to
progressive dysfunction of cognition, memory and learning in elderly people. Common …

The potential benefits of nanotechnology in treating Alzheimer's disease

TS Ling, S Chandrasegaran, LZ Xuan… - BioMed research …, 2021 - Wiley Online Library
Alzheimer's disease is a neurodegenerative disorder that is caused by the accumulation of
beta‐amyloid plaques in the brain. Currently, there is no definitive cure available to treat …

[HTML][HTML] Advances on therapeutic strategies for Alzheimer's disease: from medicinal plant to nanotechnology

NA Hassan, AK Alshamari, AA Hassan, MG Elharrif… - Molecules, 2022 - mdpi.com
Alzheimer's disease (AD) is a chronic dysfunction of neurons in the brain leading to
dementia. It is characterized by gradual mental failure, abnormal cognitive functioning …

Neurotherapeutic applications of nanoparticles in Alzheimer's disease

JK Sahni, S Doggui, J Ali, S Baboota, L Dao… - Journal of Controlled …, 2011 - Elsevier
A rapid increase in incidence of neurodegenerative disorders has been observed with the
aging of the population. Alzheimer's disease (AD) is the most common neurodegenerative …

A review on advances of treatment modalities for Alzheimer's disease

ES Thoe, A Fauzi, YQ Tang, S Chamyuang, AYY Chia - Life sciences, 2021 - Elsevier
Alzheimer's disease (AD) is a multifactorial neurodegenerative disease which is mainly
characterized by progressive impairment in cognition, emotion, language and memory in …

[HTML][HTML] Advances in developing therapeutic strategies for Alzheimer's disease

TT Nguyen, TTD Nguyen, TKO Nguyen, TK Vo - Biomedicine & …, 2021 - Elsevier
Alzheimer's disease (AD) is a progressive deterioration of brain function, initially
characterized by cognitive deficits, with loss of recent memory and language ability …

Multifunctional nanocarriers for Alzheimer's disease: befriending the barriers

MA Ansari, T Tripathi, B Venkidasamy, A Monziani… - Molecular …, 2024 - Springer
Neurodegenerative diseases (NDDs) have been increasing in incidence in recent years and
are now widespread worldwide. Neuronal death is defined as the progressive loss of …

Innovative therapies and nanomedicine applications for the treatment of Alzheimer's disease: a state-of-the-art (2017–2020)

A Binda, C Murano, I Rivolta - International Journal of …, 2020 - Taylor & Francis
The field of nanomedicine is constantly expanding. Since the first work dated in 1999, almost
28 thousand articles have been published, and more and more are published every year …